Is Technology Hindering Visibility?
The ineffectiveness of IT systems may fog decision making. Timely access to information is vital to the decision making process. Yet, the vast majority of […]
Is Technology Hindering Visibility? Read More »
With Growth Rates Stagnating In Developed Markets, What Is A Med-Tech Exec To Do?
Push for growth in emerging markets like Brazil, Russia, India and China (BRIC). For some Med-Tech Companies, growth rates in emerging markets are double, triple
With Growth Rates Stagnating In Developed Markets, What Is A Med-Tech Exec To Do? Read More »
Podcast: 2013 Medical Device Industry Outlook
On this Manufacturing Geek podcast, Daniel R. Matlis of Axendia, discusses his outlook on the issues and opportunities for Medical Device Manufacturing in 2013. This
Podcast: 2013 Medical Device Industry Outlook Read More »
Navigating the Risks and Rewards of Med-Tech Globalization Research Report
By Axendia Staff We have received very positive feedback from media outlets and industry executives on our Med-Tech Research report. We also heard that it
Navigating the Risks and Rewards of Med-Tech Globalization Research Report Read More »
Is a picture worth 8872 words? You decide
By Axendia Staff It has been said that a picture is worth 1000 words, and our research team agrees. Therefore, we have distilled some of
Is a picture worth 8872 words? You decide Read More »
FedEx Offers Blankets to Keep Pharma Clients Cool
By Daniel R. Matlis Last month, I had the opportunity to meet with Richard W. Smith, Managing Director – Life Sciences and Specialty Services at
FedEx Offers Blankets to Keep Pharma Clients Cool Read More »
Do You Need to Develop a Quality Backbone?
By Axendia Staff In business, the only constant is change. New markets open up, disruptive products are developed, competitive landscapes change and internal environments must
Do You Need to Develop a Quality Backbone? Read More »
Why Life-Sciences Distributors may be more Vulnerable to Products Liability than They Realize
By Courtney A. Stevens, Esq., Loss Control Staff Attorney, Medmarc Insurance Group Although most life-sciences companies today are likely aware of the increasing threat of
USP Workshop on Best Practices to Help Ensure Supply Chain Integrity
By Desmond Hunt, Ph.D., Senior Scientific Liaison at USP As the pharmaceutical industry continues to globalize, the challenges of securing complex supply chains and protecting
USP Workshop on Best Practices to Help Ensure Supply Chain Integrity Read More »
Taking a Cue from Aerospace & Defense
By Doug Russell, Vice President of Supply Chain Solutions, Exostar We all like to think our industries present unique challenges to overcome. While that may
Taking a Cue from Aerospace & Defense Read More »
What Industry Trends Keep You up at Night?
By Daniel R. Matlis Last year, I had breakfast with Dave Johnson, CEO of ConvaTec Inc. at “CEO Unplugged,” During the session; Mr. Johnson discussed
What Industry Trends Keep You up at Night? Read More »
The Most Important Proposed FDA Rule No One Is Talking About
By James McCormack PhD On February 19, 2010, FDA published a proposed rule [75 FR 7412] that, when finalized, will have a profound effect on
The Most Important Proposed FDA Rule No One Is Talking About Read More »